Guangdong Hybribio Biotech Co (SZSE:300639) FCF Margin % : -58.95% (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Guangdong Hybribio Biotech Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Guangdong Hybribio Biotech Co's Free Cash Flow for the three months ended in Mar. 2024 was ¥-107.9 Mil. Guangdong Hybribio Biotech Co's Revenue for the three months ended in Mar. 2024 was ¥183.1 Mil. Therefore, Guangdong Hybribio Biotech Co's FCF Margin % for the quarter that ended in Mar. 2024 was -58.95%.

As of today, Guangdong Hybribio Biotech Co's current FCF Yield % is -2.36%.

The historical rank and industry rank for Guangdong Hybribio Biotech Co's FCF Margin % or its related term are showing as below:

SZSE:300639' s FCF Margin % Range Over the Past 10 Years
Min: -23.61 Med: -4.69 Max: 10.27
Current: -9.3

During the past 12 years, the highest FCF Margin % of Guangdong Hybribio Biotech Co was 10.27%. The lowest was -23.61%. And the median was -4.69%.

SZSE:300639's FCF Margin % is ranked better than
51.35% of 222 companies
in the Medical Diagnostics & Research industry
Industry Median: -10.815 vs SZSE:300639: -9.30

Guangdong Hybribio Biotech Co FCF Margin % Historical Data

The historical data trend for Guangdong Hybribio Biotech Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangdong Hybribio Biotech Co FCF Margin % Chart

Guangdong Hybribio Biotech Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-11.48

1.79

-0.36

10.27

-5.95

Guangdong Hybribio Biotech Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-27.16	-32.25	18.38	27.45	-58.95

Competitive Comparison of Guangdong Hybribio Biotech Co's FCF Margin %

For the Diagnostics & Research subindustry, Guangdong Hybribio Biotech Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guangdong Hybribio Biotech Co's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Guangdong Hybribio Biotech Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Guangdong Hybribio Biotech Co's FCF Margin % falls into.

Guangdong Hybribio Biotech Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Guangdong Hybribio Biotech Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-65.723	/	1104.454
	=	-5.95 %

Guangdong Hybribio Biotech Co's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-107.939	/	183.101
	=	-58.95 %

Guangdong Hybribio Biotech Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Guangdong Hybribio Biotech Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Guangdong Hybribio Biotech Co (SZSE:300639) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Guangdong Hybribio Biotech Co Ltd (SZSE:300639) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

D 5-3-3-4, North High-tech Zone, Economic Development Zone, Chaozhou City, CHN, 521000

Website

http://www.hybribio.cn

Guangdong Hybribio Biotech Co Ltd is a Chinese company engaged in offering vitro diagnostic assays. Its products include in-vitro diagnostic kits, female sample collection kit, DNA extraction kit, and other devices. The company's products help in the infectious pathogens detection and genetic disease detection, including human papillomavirus, thalassemia, G6PD, hearing loss susceptibility, phenylketonuria, and early cancer detection, among others. The company has a business presence in China and various other countries.

Guangdong Hybribio Biotech Co (SZSE:300639) Headlines

No Headlines